Endpoints News 生物医药· Max Bayer·· 2 天前精选AI 评分75
FDA 批准用于治疗婴儿型尼曼-皮克病 C 型的药物
Beren wins FDA approval for long-studied rare disease drug
AI 导读
FDA 批准了一种由政府科学家设计的药物,用于治疗婴儿型尼曼-皮克病 C 型。
推荐理由
FDA 批准了用于治疗婴儿型尼曼-皮克病 C 型的药物,读者可了解同类药物的审批进展。
正文
A molecule designed by government scientists more than a decade ago has won FDA approval to treat infantile-onset Niemann-Pick disease type C, capping a winding …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news